Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation.

MLA

Gu, Sean X., et al. “Thrombocytopathy and Endotheliopathy: Crucial Contributors to COVID-19 Thromboinflammation.” Nature Reviews. Cardiology, vol. 18, no. 3, Mar. 2021, pp. 194–209. EBSCOhost, https://doi.org/10.1038/s41569-020-00469-1.

APA

Gu, S. X., Tyagi, T., Jain, K., Gu, V. W., Lee, S. H., Hwa, J. M., Kwan, J. M., Krause, D. S., Lee, A. I., Halene, S., Martin, K. A., Chun, H. J., & Hwa, J. (2021). Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nature Reviews. Cardiology, 18(3), 194–209. https://doi.org/10.1038/s41569-020-00469-1

Chicago

Gu, Sean X, Tarun Tyagi, Kanika Jain, Vivian W Gu, Seung Hee Lee, Jonathan M Hwa, Jennifer M Kwan, et al. 2021. “Thrombocytopathy and Endotheliopathy: Crucial Contributors to COVID-19 Thromboinflammation.” Nature Reviews. Cardiology 18 (3): 194–209. doi:10.1038/s41569-020-00469-1.